The K and their last Q have a lot of missing information considering BNGI was formed in 2018.
PUBLISH DATE TITLE PERIOD END DATE STATUS 09/13/2019 Notification of Late Filing - Notification of Late Filing 07/31/2019 A 08/20/2019 Quarterly Report - BNGI-Quarterly Disclosure Report 04-30-19 04/30/2019 A 06/14/2019 Notification of Late Filing - Notification of Late Filing 04/30/2019 A 06/03/2019 Supplemental Information - Compass Biotechnologies Inc. - Audited Annual Financial Statements 01/31/2019 A 03/25/2019 Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information 01/31/2019 A 03/25/2019 Annual Report - COBI-Annual Disclosure Report 2019 01/31/2019
CHICAGO, Nov. 19, 2018 /PRNewswire/ -- Bangi Investments, LLC has acquired publicly traded company Compass Biotechnologies, Inc. (Stock Symbol OTC: COBI) to gain greater access to public markets and to continue expanding its success in the cannabis marketspace. The company will go by the name BANGI, (pronounced bon-ghee), which is a noun in the African dialect Swahili meaning "marijuana" or "hemp".
"Real Estate is agnostic to the cannabis industry; every sector from cultivation to extracting and retail relies heavily upon it. I'm excited about the prospects in store for BANGI, and I will be instrumental in this transition over the next 90 days," said Rick Shykora, CEO of Compass Biotechnologies, Inc.